Is It Time To Reassess Veeva Systems (VEEV) After Its Recent Share Price Slide

Simply Wall St.

Mar 20

If you have been wondering whether Veeva Systems at around US$184 per share looks like a bargain or not, this breakdown will help you weigh the price against the underlying business. The stock has ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2620827537"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2620827537\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2620827537?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","is_english":true,"pubTime":"2026-03-20 02:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2620827537","market":"hk","top_or_hot":-1,"title":"Is It Time To Reassess Veeva Systems (VEEV) After Its Recent Share Price Slide","media":"Simply Wall St.","content":"<div>\n<p>If you have been wondering whether Veeva Systems at around US$184 per share looks like a bargain or not, this breakdown will help you weigh the price against the underlying business. The stock has ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-veev/veeva-systems/news/is-it-time-to-reassess-veeva-systems-veev-after-its-recent-s\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is It Time To Reassess Veeva Systems (VEEV) After Its Recent Share Price Slide</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs It Time To Reassess Veeva Systems (VEEV) After Its Recent Share Price Slide\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-20 02:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-veev/veeva-systems/news/is-it-time-to-reassess-veeva-systems-veev-after-its-recent-s><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you have been wondering whether Veeva Systems at around US$184 per share looks like a bargain or not, this breakdown will help you weigh the price against the underlying business. The stock has ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-veev/veeva-systems/news/is-it-time-to-reassess-veeva-systems-veev-after-its-recent-s\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0170899867.USD","symbol_name":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-veev/veeva-systems/news/is-it-time-to-reassess-veeva-systems-veev-after-its-recent-s","article_id":"2620827537","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-veev/veeva-systems/news/is-it-time-to-reassess-veeva-systems-veev-after-its-recent-s","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2620827537","pubTimestamp":1773943976,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"If you have been wondering whether Veeva Systems at around US$184 per share looks like a bargain or not, this breakdown will help you weigh the price against the underlying business.\nThe stock has seen mixed returns, with a 5.7% gain over the last 30 days, set against a 22.4% decline over the past year and a 16.2% decline year to date.\nRecent coverage has focused on how investors are reassessing higher growth software names, with attention on valuation discipline and selectivity across...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","BK4504":"桥水持仓","LU0058720904.USD":"联博国际健康护理基金A","LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","VEEV":"Veeva Systems Inc.","BK4528":"SaaS概念","BK4588":"碎股","BK4534":"瑞士信贷持仓","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","BK4613":"AI应用软件","BK4585":"ETF&股票定投概念","LU1989764748.USD":"东方汇理环球颠覆性机遇A2 Acc","DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","BK4167":"医疗保健技术","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC"},"translate_title":"Veeva Systems(VEEV)近期股价下滑后，是时候重新评估其股价了吗","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DCF":1,"VEEV":1.5},"content_text":"If you have been wondering whether Veeva Systems at around US$184 per share looks like a bargain or not, this breakdown will help you weigh the price against the underlying business. The stock has seen mixed returns, with a 5.7% gain over the last 30 days, set against a 22.4% decline over the past year and a 16.2% decline year to date. Recent coverage has focused on how investors are reassessing higher growth software names, with attention on valuation discipline and selectivity across healthcare and cloud software stocks. For Veeva Systems, this context helps explain why the share price has been under pressure even as interest in quality software names remains high. Veeva Systems holds a valuation score of 3 out of 6, and the rest of this article will walk through how different valuation approaches arrive at that number and point to a way of understanding valuation that goes beyond a single score.  Veeva Systems delivered -22.4% returns over the last year. See how this stacks up to the rest of the Healthcare Services industry. AdvertisementApproach 1: Veeva Systems Discounted Cash Flow (DCF) Analysis A Discounted Cash Flow, or DCF, model takes projected future cash flows, discounts them back to today using a required return, and sums them to estimate what the business could be worth per share right now. For Veeva Systems, the model used is a 2 Stage Free Cash Flow to Equity approach, based on cash flows in $. The latest twelve month free cash flow is about $1.39b. Analysts provide explicit free cash flow estimates out to 2031, with Simply Wall St extrapolating further years beyond those analyst inputs. By 2031, projected free cash flow used in the model is $2.44b, with intermediate annual projections between 2026 and 2035 ranging from roughly $1.33b to $3.17b before discounting. After discounting these projected cash flows back to today, the DCF model arrives at an estimated intrinsic value of about $269.48 per share, compared with the current share price of around $184. On this basis, the model implies the stock is about 31.7% undervalued. Result: UNDERVALUED Our Discounted Cash Flow (DCF) analysis suggests Veeva Systems is undervalued by 31.7%. Track this in your watchlist or portfolio, or discover 49 more high quality undervalued stocks. VEEV Discounted Cash Flow as at Mar 2026 Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Veeva Systems. Approach 2: Veeva Systems Price vs Earnings For profitable companies like Veeva Systems, the P/E ratio is a commonly used gauge because it links what you pay for each share to the earnings that the business is currently generating. It gives you a simple way to relate share price to underlying profitability. What counts as a “normal” P/E often reflects how fast earnings are expected to grow and how risky those earnings appear. Higher expected growth or lower perceived risk can justify a higher P/E, while slower growth or higher risk usually point to a lower multiple. Veeva Systems currently trades on a P/E of 33.28x. That sits above the Healthcare Services industry average of about 29.70x and the peer average of 29.67x. Simply Wall St also calculates a proprietary “Fair Ratio” for Veeva Systems of 31.02x, which is the P/E it might trade on given factors such as its earnings growth profile, industry, profit margins, market cap and risk characteristics. Because the Fair Ratio blends these company specific factors, it can give a more tailored view than a simple comparison with peers or the broad industry. With Veeva Systems at 33.28x against a Fair Ratio of 31.02x, the shares look somewhat expensive on this metric. Result: OVERVALUED NYSE:VEEV P/E Ratio as at Mar 2026 P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies. Upgrade Your Decision Making: Choose your Veeva Systems Narrative Earlier it was mentioned that there is an even better way to understand valuation, so Narratives are introduced as a simple story you choose about Veeva Systems that ties your view of its future revenue, earnings and margins to a fair value, then compares that to the current price to help inform your decision making. On Simply Wall St, Narratives sit inside the Community page and let you connect the qualitative story you believe, such as AI agents improving workflows or CRM competition limiting growth, directly to a set of financial forecasts and an implied fair value. These Narratives are refreshed automatically when new information comes in, such as earnings updates, guidance changes or new analyst targets. This helps keep your view of fair value aligned with the latest data without you needing to rebuild a model each time. For Veeva Systems, one investor might align with a more optimistic Narrative using a fair value around US$380.00, while another might prefer a cautious Narrative closer to US$232.80. By comparing each fair value to the live share price, you can decide which story you find more reasonable and how that influences your own next step. Do you think there's more to the story for Veeva Systems? Head over to our Community to see what others are saying! NYSE:VEEV 1-Year Stock Price Chart  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}